Vimarsana
Biggest News Aggregation in the World

Page 24 - Multiple Sclerosis Centers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Centers Today - Breaking & Trending Today

Ocrelizumab Safe and Effective for Early-Stage Relapsing-Remitting MS - Vimarsana News

Ocrelizumab Safe and Effective for Early-Stage Relapsing-Remitting MS

Ocrelizumab is safe and effective and provides long-term benefits for treatment-naïve patients with early-stage relapsing-remitting multiple sclerosis.

Cognition Impacts Social Activity Participation in Multiple Sclerosis - Vimarsana News

Cognition Impacts Social Activity Participation in Multiple Sclerosis

The impact of cognition on social roles and activities suggests the need of taking a closer look at cognitive impairment in patients with multiple sclerosis.

Long-Term Satralizumab Safe in Patients with Neuromyelitis Optica Spectrum Disorder - Vimarsana News

Long-Term Satralizumab Safe in Patients with Neuromyelitis Optica Spectrum Disorder

Long-term treatment of neuromyelitis optica spectrum disorder with satralizumab is safe and effective in reducing relapse risk in patients.

Multiple Sclerosis Management and Care: How a Tele-Monitoring Tool May Help - Vimarsana News

Multiple Sclerosis Management and Care: How a Tele-Monitoring Tool May Help

Icompanion may be a helpful tele-monitoring tool in encouraging more patient involvement and data-driven clinical decisions for multiple sclerosis care.

For MS Pain: Focus on Flexibility, Nondrug Treatments - Vimarsana News

For MS Pain: Focus on Flexibility, Nondrug Treatments

When treating pain in multiple sclerosis, a specialist is urging colleagues to think outside the box - especially since pain can evolve over time due to changes in MS and related conditions.